Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system

Despite explosive growth in the development of nano-drug delivery systems (NDDS) targeting tumors in the last few decades, clinical translation rates are low owing to the lack of efficient models for evaluating and predicting responses. Microfluidics-based tumor-on-a-chip (TOC) systems provide a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Chutong, Zheng, Shunzhe, Liu, Xinying, Kamei, Ken-ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301849/
https://www.ncbi.nlm.nih.gov/pubmed/35858898
http://dx.doi.org/10.1186/s12951-022-01552-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301849/
https://www.ncbi.nlm.nih.gov/pubmed/35858898
http://dx.doi.org/10.1186/s12951-022-01552-0

Ejemplares similares